Drug intelligence / Profile preview

Kabiven (Fresenius Kabi)

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Intravenous
01

Overview

Three-chamber bags (3CB) from Fresenius Kabi, most notably marketed under the brand names **Kabiven** and **SmofKabiven**, are all-in-one parenteral nutrition systems designed for the treatment of malnutrition. These products consist of a plastic bag with three separate compartments containing amino acids (with electrolytes), a dextrose solution, and a lipid emulsion. The compartments are separated by peel-seals that are broken and mixed immediately prior to intravenous administration. This design ensures the stability of the individual components during storage while providing a convenient, standardized, and sterile 'all-in-one' mixture for the patient. Kabiven utilizes a soybean oil-based lipid emulsion, whereas SmofKabiven contains SMOFlipid, a four-oil blend (soybean, medium-chain triglycerides, olive, and fish oil) designed to provide a more balanced fatty acid profile. Clinical studies comparing 3CBs to hospital-compounded parenteral nutrition have demonstrated that these standardized bags can reduce the risk of bloodstream infections and medication errors.

Brand names
KabivenSmofKabivenPerikabivenStructoKabiven
Other names
3-chamber bag3CBTriple-chamber bagAll-in-one parenteral nutritionFresenius Kabi three-chamber bag

Beyond the preview

Go deeper on Kabiven (Fresenius Kabi).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kabiven (Fresenius Kabi).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call